Protection of oral hydrogen water as an antioxidant on pulmonary hypertension

Molecular Biology Reports

Volumn 40, Issue 9, 2013, Pages 5513-5521

  He, Bin ^a   Zhang, Yufeng ^b   Kang, Bo ^b   Xiao, Jian ^b   Xie, Bing ^c   Wang, Zhinong ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Antioxidant; Hydrogen water; Pulmonary hypertension

Indexed keywords

3 NITROTYROSINE; ATRIAL NATRIURETIC FACTOR; BETA ACTIN; HYDROGEN; INTERCELLULAR ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; HEART RIGHT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE VOLUME; HEART WEIGHT; LUNG ARTERY PRESSURE; LUNG INJURY; MEAN ARTERIAL PRESSURE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RAT; UPREGULATION;

RATTUS;

ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; BLOTTING, WESTERN; HYDROGEN; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; INTERCELLULAR ADHESION MOLECULE-1; MODELS, ANIMAL; MONOCROTALINE; RATS;

EID: 84883265918     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-013-2653-9     Document Type: Article

References (34)

1. Rich S, Chomka E, Hasara L, Hart K, Drizd T, Joo E, Levy PS (1989) The prevalence of pulmonary hypertension in the United States. Adult population estimates obtained from measurements of chest roentgenograms from the NHANES II Survey. Chest 96:236-241
2. Hassoun PM, Mouthon L, Barberà JA, Eddahibi S, Flores SC, Grimminger F, Jones PL, Maitland ML, Michelakis ED, Morrell NW, Newman JH, Rabinovitch M, Schermuly R, Stenmark KR, Voelkel NF, Yuan JX, Humbert M (2009) Inflammation, growth factors, and pulmonary vascular remodeling. J Am Coll Cardiol 54:S10-S19
3. Morrell NW, Adnot S, Archer SL, Dupuis J, Jones PL, MacLean MR, McMurtry IF, Stenmark KR, Thistlethwaite PA, Weissmann N, Yuan JX, Weir EK (2009) Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 54:S20-S31
4. Chan SY, Loscalzo J (2008) Pathogenic mechanisms of pulmonary arterial hypertension. J Mol Cell Cardiol 44:14-30
5. Machado RD, Eickelberg O, Elliott CG, Geraci MW, Hanaoka M, Loyd JE, Newman JH, Phillips JA 3rd, Soubrier F, Trembath RC, Chung WK (2009) Genetics and genomics of pulmonary arterial hypertension. J Am Coll Cardiol 54:S32-S42
6. Lai YL, Law TC (2004) Chronic hypoxia- and monocrotaline-induced elevation of hypoxia-inducible factor-1 alpha levels and pulmonary hypertension. J Biomed Sci 11:315-321
7. Chen YF, Jowett S, Barton P, Malottki K, Hyde C, Gibbs JS, Pepke-Zaba J, Fry-Smith A, Roberts J, Moore D (2009) Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation. Health Technol Assess 13:1-320
8. Beghetti M (2006) Current treatment options in children with pulmonary arterial hypertension and experiences with oral bosentan. Eur J Clin Invest 36:16-24
9. Ghofrani HA, Barst RJ, Benza RL, Champion HC, Fagan KA, Grimminger F, Humbert M, Simonneau G, Stewart DJ, Ventura C, Rubin LJ (2009) Future perspectives for the treatment of pulmonary arterial hypertension. J Am Coll Cardiol 54:S108-S117
10. Firth AL, Yuan JX (2008) Bringing down the ROS: a new therapeutic approach for PPHN. Am J Physiol Lung Cell Mol Physiol 295:L976-L978
11. Fresquet F, Pourageaud F, Leblais V, Brandes RP, Savineau JP, Marthan R, Muller B (2006) Role of reactive oxygen species and gp91phox in endothelial dysfunction of pulmonary arteries induced by chronic hypoxia. Br J Pharmacol 148:714-723
12. Aziz SM, Toborek M, Hennig B, Mattson MP, Guo H, Lipke DW (1997) Oxidative stress mediates monocrotaline-induced alterations in tenascin expression in pulmonary artery endothelial cells. Int J Biochem Cell Biol 29:775-787
13. Gong Y, Yi M, Fediuk J, Lizotte PP, Dakshinamurti S (2010) Hypoxic neonatal pulmonary arterial myocytes are sensitized to ROS-generated 8-isoprostane. Free Radic Biol Med 48:882-894
14. AfanaÅev I (2011) ROS and RNS signaling in heart disorders: could antioxidant treatment be successful. Oxid Med Cell Longev 2011:293769
15. Zhang TT, Cui B, Dai DZ, Tang XY (2005) Pharmacological efficacy of CPU 86017 on hypoxic pulmonary hypertension in rats: mediated by direct inhibition of calcium channels and antioxidant action, but indirect effects on the ET-1 pathway. J Cardiovasc Pharmacol 46:727-734
16. Csiszar A, Labinskyy N, Olson S, Pinto JT, Gupte S, Wu JM, Hu F, Ballabh P, Podlutsky A, Losonczy G, de Cabo R, Mathew R, Wolin MS, Ungvari Z (2009) Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats. Hypertension 54:668-675
17. Sauer H, Wartenberg M, Hescheler J (2001) Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem 11:173-186
18. Liu H, Colavitti R, Rovira II, Finkel T (2005) Redox-dependent transcriptional regulation. Circ Res 97:967-974
19. Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, Katsura K, Katayama Y, Asoh S, Ohta S (2007) Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med 13:688-694
20. Gu Y, Huang CS, Inoue T, Yamashita T, Ishida T, Kang KM, Nakao A (2010) Drinking hydrogen water ameliorated cognitive impairment in senescence- accelerated mice. J Clin Biochem Nutr 46:269-276
21. Mao YF, Zheng XF, Cai JM, You XM, Deng XM, Zhang JH, Jiang L, Sun XJ (2009) Hydrogen-rich saline reduces lung injury induced by intestinal ischemia/reperfusion in rats. Biochem Biophys Res Commun 381:602-605
22. Zhang Y, Sun Q, He B, Xiao J, Wang Z, Sun X (2011) Anti-inflammatory effect of hydrogen-rich saline in a rat model of regional myocardial ischemia and reperfusion. Int J Cardiol 148:91-95
23. Baybutt RC, Molteni A (1999) Dietary beta-carotene protects lung and liver parenchyma of rats treated with monocrotaline. Toxicology 137:69-80
24. Klinger JR, Petit RD, Curtin LA, Warburton RR, Wrenn DS, Steinhelper ME, Field LJ, Hill NS (1993) Cardiopulmonary responses to chronic hypoxia in transgenic mice that overexpress ANP. J Appl Physiol 75:198-205
25. He B, Xiao J, Ren AJ, Zhang YF, Zhang H, Chen M, Xie B, Gao XG, Wang YW (2011) Role of miR-1 and miR-133a in myocardial ischemic postconditioning. J Biomed Sci 18:22
26. Jeffery TK, Morrell NW (2002) Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension. Prog Cardiovasc Dis 45:173-202
27. Redout EM, Wagner MJ, Zuidwijk MJ, Boer C, Musters RJ, van Hardeveld C, Paulus WJ, Simonides WS (2007) Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen species. Cardiovasc Res 75:770-781
28. Pullamsetti SS, Savai R, Janssen W, Dahal BK, Seeger W, Grimminger F, Ghofrani HA, Weissmann N, Schermuly RT (2011) Inflammation, immunological reaction and role of infection in pulmonary hypertension. Clin Microbiol Infect 17:7-14
29. Li PC, Li SC, Lin YJ, Liang JT, Chien CT, Shaw CF (2005) Thoracic vagal efferent nerve stimulation evokes substance P-induced early airway bronchonstriction and late proinflammatory and oxidative injury in the rat respiratory tract. J Biomed Sci 12:671-681
30. Zhu Y, Zhang XL, Zhu BF, Ding YN (2012) Effect of antioxidant N-acetylcysteine on diabetic retinopathy and expression of VEGF and ICAM-1 from retinal blood vessels of diabetic rats. Mol Biol Rep 39:3727-3735
31. Black SM, Fineman JR (2006) Oxidative and nitrosative stress in pediatric pulmonary hypertension: roles of endothelin-1 and nitric oxide. Vascul Pharmacol 45:308-316
32. Patel JD, Krupka T, Anderson JM (2007) iNOS-mediated generation of reactive oxygen and nitrogen species by biomaterial-adherent neutrophils. J Biomed Mater Res A 80:381-390
33. Murad F (2004) Discovery of some of the biological effects of nitric oxide and its role in cell signaling. Biosci Rep 24:452-474
34. Winterbourn CC (2002) Biological reactivity and biomarkers of the neutrophil oxidant, hypochlorous acid. Toxicology 181-182:223-227